Latest & greatest articles for adhd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adhd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adhd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

ADHD

ADHD (or Attention deficit hyperactivity disorder) is a neurodevelopmental type mental disorder. It is characterised two main categories of two types of behavioural problems:

  • inattentiveness
  • hyperactivity and impulsiveness

Most people with ADHD have problems that fall into both categories, but it doesn’t have to be the case. If a person just has inattentiveness it is referred to as attention deficit disorder (ADD).

Methylphenidate is a commonly used medication used to treat patients suffering from attention-deficit hyperactivity disorder. Methylphenidate is part of a group of drugs known as stimulants. Central nervous system stimulants help change the amounts of natural substances in the brain. But it is not the only intervention; others include Bupropion, exercise and CBT (Cognitive behavioural therapy).

Extensive ADHD research and case studies have been carried out over numerous years. Trip has unrivalled coverage of the evidence base including systematic reviews, clinical trials, clinical guidelines and case studies.

Studies are ongoing to assess the safety and effectiveness of stimulants used on children with ADHD and intellectual disabilities as well as in other populations and other interventions. Trip also includes ongoing controlled trials and ongoing systematic reviews (via the PROSPERO database).

Top results for adhd

141. The experiences of children and adolescents living with ADHD were reflected in 6 themes

The experiences of children and adolescents living with ADHD were reflected in 6 themes The experiences of children and adolescents living with ADHD were reflected in 6 themes | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword (...) Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here The experiences of children and adolescents living with ADHD were reflected in 6 themes Article Text Qualitative The experiences of children and adolescents living with ADHD were reflected in 6 themes Free Lynda W Slimmer , RN, PhD Statistics from Altmetric.com No Altmetric data

Evidence-Based Nursing (Requires free registration)2005

142. Review: stimulant pharmacotherapy for children with ADHD is associated with a reduced risk of later substance abuse disorder

Review: stimulant pharmacotherapy for children with ADHD is associated with a reduced risk of later substance abuse disorder Review: stimulant pharmacotherapy for children with ADHD is associated with a reduced risk of later substance abuse disorder | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your (...) user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: stimulant pharmacotherapy for children with ADHD is associated with a reduced risk of later substance abuse disorder Article Text Aetiology Review: stimulant pharmacotherapy for children with ADHD is associated with a reduced risk of later substance

Evidence-Based Medicine (Requires free registration)2004

143. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies

Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies Cohen-Zion M, Ancoli-Israel S CRD summary This review assessed the effects of psychostimulants on sleep (...) in children with attention-deficit hyperactivity disorder. The authors found limited evidence to suggest a possible increase in some sleep complaints, but concluded that further studies are required. Despite some methodological limitations to this review, the authors' cautious conclusions and recommendation for further research appear reasonable. Authors' objectives To assess the relationship between attention-deficit hyperactivity disorder (ADHD) symptomatology and sleep, and the effects

DARE.2004

144. Cost-effectiveness of methylphenidate versus AMP/DEX mixed slats for the first-line treatment of ADHD

Cost-effectiveness of methylphenidate versus AMP/DEX mixed slats for the first-line treatment of ADHD Cost-effectiveness of methylphenidate versus AMP/DEX mixed slats for the first-line treatment of ADHD Cost-effectiveness of methylphenidate versus AMP/DEX mixed slats for the first-line treatment of ADHD Narayan S, Hay J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of methylphenidate (MPH) versus amphetamine/dextroamphetamine mixed salts (AMP/DEX) as first-line agents for the treatment of attention deficit hyperactivity disorder (ADHD) was studied. Type of intervention Treatment. Economic study type Cost-utility analysis. Study population The study population comprised a hypothetical cohort of male children aged

NHS Economic Evaluation Database.2004

145. Efficacy of stimulants in adult ADHD

Efficacy of stimulants in adult ADHD Efficacy of stimulants in adult ADHD Efficacy of stimulants in adult ADHD Maidment I D CRD summary This review assessed stimulants as a treatment for adults with attention-deficit hyperactivity disorder. The quality of most of the studies was poor and there is little evidence on the effectiveness of long-term treatment. It is reasonable for the author to conclude that stimulants may be effective. Authors' objectives To assess the efficacy of stimulants (...) to treat adults with attention-deficit hyperactivity disorder (ADHD). Searching MEDLINE was searched from 1966 to 2002; the search terms were reported. The reference lists in identified articles were checked and drug manufacturers were contacted. Studies reported in English were eligible for inclusion in the review. Study selection Study designs of evaluations included in the review Eligibility criteria were not stated. The review included mostly double-blind trials of a crossover design, a few

DARE.2003

146. Psychopharmacology and aggression - 1: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.

Psychopharmacology and aggression - 1: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. Psychopharmacology and aggression - 1: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. Psychopharmacology and aggression - 1: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. Connor D F, Glatt S J, Lopez I D, Jackson D, Melloni R H Authors' objectives To determine by meta-analysis (...) the effect size for stimulants on overt and covert aggression-related behaviours in children with attention-deficit hyperactivity disorder (ADHD), separately from stimulant effects on the core symptoms of ADHD. Searching MEDLINE and PubMed were searched from 1970 to 2001 using keywords that were reported in the paper. The bibliographies of relevant journals were also searched. The searches were limited to English language studies. Only studies published in a peer-reviewed scientific journal were included

DARE.2002

148. Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD)

Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD) Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD) Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD) Hender K Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Hender K (...) . Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD) Clayton, Victoria: Centre for Clinical Effectiveness (CCE) 2001: 7 Authors' objectives This aim of this critical appraisal was to assess the effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD). Project page URL Indexing Status Subject indexing assigned by CRD MeSH Attention Deficit Disorder with Hyperactivity; Child; Occupational Therapy; Physical Therapy Modalities

Health Technology Assessment (HTA) Database.2001

149. Atomoxetine for ADHD - horizon scanning review

Atomoxetine for ADHD - horizon scanning review Atomoxetine for ADHD - horizon scanning review Atomoxetine for ADHD - horizon scanning review NHSC Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NHSC. Atomoxetine for ADHD - horizon scanning review. Birmingham: National Horizon Scanning Centre (NHSC). New and Emerging Technology Briefing (...) . 2001 Authors' objectives To summarise the current research evidence on atomoxetine for attention deficit hyperactivity disorder (ADHD). Authors' conclusions - Clinical impact: There is likely to be a significant clinical impact from the introduction of atomoxetine due to the fact that it will be the first non-stimulant drug therapy licensed for the treatment of ADHD. - Service impact: Although there is unlikely to be a significant service impact with the introduction of atomoxetine for people

Health Technology Assessment (HTA) Database.2001

150. The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD)

The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD) The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD) The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD) Smith B H, Waschbusch D A, Willoughby M T, Evans S Authors' objectives To review studies of interventions for adolescents diagnosed (...) with attention-deficit/hyperactivity disorder (ADHD) in order to evaluate the efficacy of the interventions. Searching MEDLINE, ERIC and PsycLIT were searched using the following keywords: 'treatment', 'adolescent', 'teen', 'ADHD', 'hyperactive', 'inattentive', and 'stimulant'. Further studies were identified from references in the review papers. No restrictions on publication language were reported. Study selection Study designs of evaluations included in the review Empirical studies were included. Specific interventions included

DARE.2000

151. Methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood

Methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood Methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood Methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood National Institute for Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation National Institute for Clinical Excellence. Methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood. London: National Institute for Clinical Excellence (NICE). Technology Appraisal Guidance 13. 2000 Authors' objectives To provide guidance on the use of methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood. Authors' conclusions Guidance 1.1 Methylphenidate is recommended for use as part

Health Technology Assessment (HTA) Database.2000